Urethritis/Cervicitis Pathogen Prevalence and Associated Risk Factors Among Asymptomatic HIV-Infected Patients in South Africa

Background: To determine sexually transmitted infection (STI) prevalence, and patient characteristics associated with detection of urethritis/cervicitis pathogens, among HIV-infected individuals offered voluntary STI screening at a South African HIV treatment center. Methods: Individuals, asymptomatic for genital discharge, were screened for Neisseria gonorrhoeae (NG), Chlamydia trachomatis, Trichomonas vaginalis (TV), Mycoplasma genitalium (MG) infections (real-time polymerase chain reaction assay), for syphilis and herpes simplex type 2 (serologically), and for bacterial vaginosis and Candida (microscopy, women only). Patients' most recent CD4 and viral load results were recorded. Demographic, clinical, and behavioral data were collected by nurse-administered questionnaire. Results: Compared with men (n = 551), women (n = 558) were younger (mean age, 35.0 vs. 37.9 years; P < 0.001), reported more STIs in the past year (65.5% vs. 56.5%; P = 0.002), had more urethritis/cervicitis pathogens detected (21.3% vs.16.4%, P = 0.035), and were less aware of their partner's HIV status (53.1% vs. 62.3%; P = 0.007). The overall prevalence of individual urethritis/cervicitis pathogens was TV (7.6%), MG (6.1%), NG (5.4%), and C. trachomatis (2.1%). Multivariate analysis highlighted 4 significant factors associated with the detection of specific urethritis/cervicitis pathogens, namely female gender (TV, adjusted odds ratio [aOR] 2.53, 95% confidence interval [CI]: 1.47–4.37), having a regular sexual partner in the past 3 months (NG, aOR 2.26, 95% CI: 1.01–5.08), suboptimal condom use with regular partners (TV, aOR 2.07, 95% CI: 1.25–3.42), and a history of genital warts in the past year (NG, 2.25, 95% CI: 1.26–4.03). Conclusions: Asymptomatic urethritis/cervicitis pathogens were highly prevalent in this population. Few urethritis/cervicitis pathogen-associated patient characteristics were identified, emphasizing the need for affordable STI diagnostics to screen HIV-infected patients.

[1]  Jennifer A. Pellowski,et al.  Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention , 2011, Sexually Transmitted Infections.

[2]  F. Radebe,et al.  Etiology and STI/HIV Coinfections Among Patients With Urethral and Vaginal Discharge Syndromes in South Africa , 2010, Sexually transmitted diseases.

[3]  N. Low,et al.  Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings , 2010, AIDS care.

[4]  L. Johnson,et al.  The Effect of Genital Tract Infections on HIV-1 Shedding in the Genital Tract: A Systematic Review and Meta-Analysis , 2008, Sexually transmitted diseases.

[5]  Richard G. White,et al.  Treating Curable Sexually Transmitted Infections to Prevent HIV in Africa: Still an Effective Control Strategy? , 2008, Journal of acquired immune deficiency syndromes.

[6]  R. Peeling,et al.  Rapid tests for sexually transmitted infections (STIs): the way forward , 2006, Sexually Transmitted Infections.

[7]  R. Nandwani.  2006 United Kingdom National Guideline on the Sexual Health of People with HIV: Sexually Transmitted Infections , 2006, International journal of STD & AIDS.

[8]  J. Baeten,et al.  Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. , 2006, The Journal of antimicrobial chemotherapy.

[9]  Myron S. Cohen,et al.  HIV and sexually transmitted diseases: lethal synergy. , 2004, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[10]  T. Farley,et al.  The value of screening for sexually transmitted diseases in an HIV clinic. , 2003, Journal of acquired immune deficiency syndromes.

[11]  J. Klausner,et al.  Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS , 2001, The Lancet.

[12]  R. Rothenberg,et al.  The Effect of Treating Sexually Transmitted Diseases on the Transmission of HIV in Dually Infected Persons: A Clinic‐Based Estimate , 2000, Sexually transmitted diseases.

[13]  S. Pinkerton,et al.  Sexually Transmitted Diseases and the Increased Risk for HIV Transmission: Implications for Cost‐Effectiveness Analyses of Sexually Transmitted Disease Prevention Interventions , 2000, Journal of acquired immune deficiency syndromes.

[14]  D. Fleming,et al.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.

[15]  T. Schacker,et al.  Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. , 1998, JAMA.

[16]  P. Vernazza,et al.  Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 , 1997, The Lancet.